These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9264191)

  • 1. [Receptors, genetics and malignant hyperpyrexia].
    Shapira Y; Gurman GM
    Harefuah; 1997 Jun; 132(12):849-50. PubMed ID: 9264191
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the segregation of the RYR1 C184OT mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Hogan K
    Anesthesiology; 1996 Feb; 84(2):29A-30A. PubMed ID: 8602659
    [No Abstract]   [Full Text] [Related]  

  • 3. No C1840 to T mutation in RYR1 in malignant hyperthermia.
    Hall-Curran JL; Stewart AD; Ball SP; Halsall JP; Hopkins PM; Ellis FR
    Hum Mutat; 1993; 2(4):330. PubMed ID: 8401544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary].
    Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiology and physiopathology of ryanodine receptors in swine. Significance of sensitivity to stress, stress myopathies, malignant hyperthermia and meat quality].
    Martens H
    Tierarztl Prax; 1997 Jan; 25(1):41-51. PubMed ID: 9157629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ryanodine receptor].
    Takeshima H
    Tanpakushitsu Kakusan Koso; 1997 Feb; 42(3 Suppl):230-4. PubMed ID: 9162956
    [No Abstract]   [Full Text] [Related]  

  • 7. Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms.
    Capacchione JF; Sambuughin N; Bina S; Mulligan LP; Lawson TD; Muldoon SM
    Anesthesiology; 2010 Jan; 112(1):239-44. PubMed ID: 20010423
    [No Abstract]   [Full Text] [Related]  

  • 8. [Excitation-contraction uncoupling and muscular degeneration lacking functional skeletal muscle ryanodine-receptor gene].
    Nishi M
    Tanpakushitsu Kakusan Koso; 1995 Oct; 40(14):2181-7. PubMed ID: 8532874
    [No Abstract]   [Full Text] [Related]  

  • 9. Control of calcium in skeletal muscle excitation-contraction coupling: implications for malignant hyperthermia.
    Wingertzahn MA; Ochs RS
    Mol Genet Metab; 1998 Oct; 65(2):113-20. PubMed ID: 9787103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipoint mapping of the central core disease locus.
    Schwemmle S; Wolff K; Palmucci LM; Grimm T; Lehmann-Horn F; Hübner C; Hauser E; Iles DE; MacLennan DH; Müller CR
    Genomics; 1993 Jul; 17(1):205-7. PubMed ID: 8406450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular medicine and malignant hyperthermia. A step ahead.
    Hogan K
    Anesthesiology; 1997 Mar; 86(3):511-3. PubMed ID: 9066315
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignant hyperthermia hots up!
    Johnson K
    Hum Mol Genet; 1993 Jul; 2(7):849. PubMed ID: 8395938
    [No Abstract]   [Full Text] [Related]  

  • 13. Ca2+ channels and excitation-contraction coupling.
    Ashcroft FM
    Curr Opin Cell Biol; 1991 Aug; 3(4):671-5. PubMed ID: 1663374
    [No Abstract]   [Full Text] [Related]  

  • 14. Complex pharmacology of malignant hyperthermia.
    Pessah IN; Lynch C; Gronert GA
    Anesthesiology; 1996 Jun; 84(6):1275-9. PubMed ID: 8669666
    [No Abstract]   [Full Text] [Related]  

  • 15. Haplotype analysis of the BYR1 gene in malignant hyperthermia and central core disease.
    Quane KA; Keating KE; Healy JM; Heffron JJ; Lehane M; Krivosic-Horber R; Heytens L; McCarthy TV
    Biochem Soc Trans; 1995 May; 23(2):372S. PubMed ID: 7672403
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple method to detect the RYR1 mutation G1021A, a cause of malignant hyperthermia susceptibility.
    Alestrøm A; Fagerlund TH; Berg K
    Clin Genet; 1995 May; 47(5):274-5. PubMed ID: 7554356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channels in neurological disease.
    Greenberg DA
    Ann Neurol; 1997 Sep; 42(3):275-82. PubMed ID: 9307247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of halothane gene mutation associated with malignant hyperthermia in sows dead of cardiac failure.
    Lambert AJ; Houde A; Drolet R; D'Allaire S
    J Vet Diagn Invest; 1996 Oct; 8(4):513-5. PubMed ID: 8953548
    [No Abstract]   [Full Text] [Related]  

  • 20. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.